Birznieks Gunther (CIK 1702031) reported 4 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-03-04). Recent activity: Sell VNDA (42,431 shares), Buy VNDA (125,000 shares), Sell VNDA (26,941 shares), Buy VNDA (125,000 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-03-04 | Vanda Pharmaceuticals Inc. (VNDA) | SVP, Business Development | Sell | 42,431 | $350,904 |
| 2026-02-19 | Vanda Pharmaceuticals Inc. (VNDA) | SVP, Business Development | Buy | 125,000 | $0 |
| 2025-03-04 | Vanda Pharmaceuticals Inc. (VNDA) | SVP, Business Development | Sell | 26,941 | $128,239 |
| 2025-02-20 | Vanda Pharmaceuticals Inc. (VNDA) | SVP, Business Development | Buy | 125,000 | $0 |
Source: SEC Form 4 filings · as of 2026-03-04